Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Thrombolytic therapy for ischemic stroke

https://doi.org/10.14412/2074-2711-2013-2342

Full Text:

Abstract

Systemic intravenous thrombolysis using recombinant tissue plasminogen activator (rt-PA) is a proven effective treatment in a certain category of patients with ischemic stroke during the first 4.5 hours after onset of this disease. Thrombolytic therapy (TLT) promotes the achievement of reperfusion in the cerebral ischemic portion, thus improving the patient's functional state. The results of international trials of TLP are presented and therapeutic strategies considered.

About the Author

Natalia Vyacheslavovna Pizova
Department of Neurology and Medical Genetics with Course of Neurosurgery, Yaroslavl State Medical Academy, Ministry of Health of Russia
Russian Federation


References

1. <div><p>Верещагин НВ, Варакин ЯЯ. Регистры инсульта в России: результаты и методологические аспекты проблемы. Журнал неврологии и психиатрии им. С.С. Корсакова. Инсульт. 2001;101 приложение 1):34–40. [Vereshchagin NV, Varakin YaYa. Registry insul'ta v Rossii: rezul'taty i metodologicheskie aspekty problemy. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2001;101 Suppl 1:34–40.</p><p>Виленский БС. Неотложные состояния в неврологии: Руководство для врачей. Санкт-Петербург: Фолиант; 2004. 512 с. [Vilenskiy BS. Neotlozhnye sostoyaniya v nevrologii: Rukovodstvo dlya vrachey. St.-Petersburg: Foliant; 2004. 512 p.</p><p>Ворлоу ЧП, Деннис МС, ван Гейн Ж и др. Инсульт. Практическое руководство для ведения больных. Перевод с английского. Санкт-Петербург: Политехника; 1998. 629 с. [Vorlou ChP, Dennis MS, van Geyn Zh i dr. Insul't. Prakticheskoe rukovodstvo dlya vedeniya bol'nykh. Translation from English. St.-Petersburg: Politekhnika; 1998. 629 p.]</p><p>Гусев ЕИ, Скворцова ВИ, Стаховская ЛВ. Эпидемиология инсульта в России. Журнал неврология и психиатрия им. С.С. Корсакова. Инсульт. 2003;(8):4–9. [Gusev EI, Skvortsova VI, Stakhovskaya LV. Epidemiologiya insul'ta v Rossii. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. Insul't. 2003;(8):4–9.]</p><p>Белова АН. Нейрореабилитация: Руководство для врачей. 2-е изд. Москва: Антидор; 2002. 736 с. [Belova AN. Neyroreabilitatsiya: Rukovodstvo dlya vrachey. 2-e izd. Moscow: Antidor; 2002. 736 p.]</p><p>Дамулин ИВ, Парфенов ВА, Скоромец АА, Яхно НН. Нарушения мозгового кровообращения. Болезни нервной системы. Руководство для врачей. Под ред. Яхно НН, Штульман ДР. Москва; 2003;231–302. [Damulin IV, Parfenov VA, Skoromets AA, Yakhno NN. Narusheniya mozgovogo krovoobrashcheniya. Bolezni nervnoy sistemy. Rukovodstvo dlya vrachey. Pod red. Yakhno NN, Shtul'man DR. Moscow; 2003;231–302.]</p><p>Парфенов ВА, Хасанова ДР. Ишемический инсульт. Москва: МИА; 2012. 288 с. [Parfenov VA, Khasanova DR. Ishemicheskiy insul't. Moscow: MIA; 2012. 288 p.]</p><p>Гусев ЕИ, Скворцова ВИ. Ишемия головного мозга. Москва; 2001. 328 с. [Gusev EI, Skvortsova VI. Ishemiya golovnogo mozga. Moskva; 2001. 328 p.]</p><p>Rha JH, Saver JL. The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke. 2007;38(3):967–73. Epub 2007 Feb 1.</p><p>Суслина ЗА, Пирадов МА. Инсульт. Диагностика, лечение и профилактика. Руководство для врачей. Москва; 2008. [Suslina ZA, Piradov MA. Insul't. Diagnostika, lechenie i profilaktika. Rukovodstvo dlya vrachey. Moscow; 2008.]</p><p>Guidelines for Management of Ischaemic Stroke of the European Stroke Organisation, 2008/2009. Available from: http://www.eso-stroke.org/recommendations.</p><p>Adams HP Jr, del Zoppo GJ, Alberts MJ et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke. 2007;38(5):1655-711. Epub 2007 Apr 12.</p><p>The national institute of neurological disorders and stroke rt-PA stroke study group. Tissue plasminogen activator for acute ischemic stroke. New Eng J Med. 1995;333(24):1581–7.</p><p>Hacke W, Donnan G, Fieschi C et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet. 2004;363(9411):768–74.</p><p>European Stroke Initiative Executive Committee; EUSI Writing Committee, Olsen TS et al. European Stroke Initiative Recommendations for stroke Management. Update 2003. Cerebrovasc Dis. 2003;16(4):311–37.</p><p>Del Zoppo GJ, Higashida RT, Furlan AJ et al. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. Stroke. 1998;29(1):4–11. DOI: 10.1161%2F01.STR.29.1.4.</p><p>Adams HP Jr, Brott T, Furlan A et al. Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. Circulation. 1996;94(5):1167–74.</p><p>Practice advisory: thrombolytic therapy for acute ischemic stroke – summary statement: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 1996;47(3):835–9.</p><p>Системная тромболитическая терапия при ишемическом инсульте: метод. Рекомендации. НИИ инсульта РГМУ. Под ред. Скворцовой ВИ. Москва; 2007. 70 с. [Sistemnaya tromboliticheskaya terapiya pri ishemicheskom insul'te: metod. Rekomendatsii. NII insul'ta RGMU. Pod red. Skvortsovoy VI. Moscow; 2007. 70 p.]</p><p>Hacke W, Kaste M, Fieschi C. et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute ischemic stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA. 1995;274(13):1017–25.</p><p>Hacke W, Kaste M, Fieschi C et al. Randomized double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet. 1998;352(9136):1245–51.</p><p>Clark WM, Wissman S, Albers GW. et al. Recombinant Tissue-Type Plasminogen Activator (Alteplase) for Ischemic Stroke 3 to 5 Hours After Symptom Onset. The ATLANTIS Study: A Randomized Controlled Trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA. 1999;282(21):2019–26. DOI: 10.1001%2Fjama.282.21.2019.</p><p>Hacke W, Kaste M, Bluhmki E et al. Thrombolysis with alteplase 3 to 4,5 hours after acute ischemic stroke. N Engl J Med. 2008;359(13):1317–29.DOI: 10.1056/NEJMoa0804656.</p><p>Wahlgren N, Ahmed N, Davalos A et al. Thrombolysis with alteplase 3–4,5 h after acute ischaemic stroke (SITS-ISTR): an observational study. Lancet. 2008;372(9646):1303–9. DOI: 10.1016/S0140-6736(08)61339-2. Epub 2008 Sep 12.</p><p>Wahlgren N, Ahmed N, Davalos A. et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SIST-MOST): an observational study. Lancet. 2007;369(9558):275–82.</p><p>Ahmed N, Wahlgren N, Grond M et al. Implementation and outcome of thrombolysis with alteplase 3–4,5 h after an acute stroke: an updated analysis from SITS-ISTR. Lancet Neurol. 2010;9(9):866–74. DOI: 10.1016/S1474-4422(10)70165-4. Epub 2010 Jul 26.</p><p>Lisboa C, Jovanovic BD, Alberts MJ. Analysis of the Safety and Efficacy of Intra-Arterial Thrombolytic Therapy in Ischemic Stroke. Stroke. 2002;33(12):2866–71. DOI: 10.1161%2F01.STR.0000038987.62325.14.</p><p>Lee M, Hong KS, Saver JL. Efficacy of intra-arterial fibrinolysis for acute ischemic stroke: meta-analysis of randomized controlled trials. Stroke. 2010;41(5):932–7. doi: 10.1161/STROKEAHA.109.574335. Epub 2010 Apr 1.</p><p>Alexandrov AV, Demchuk AM, Burgin WS et al. Ultrasound-enhanced thrombolysis for acute ischemic stroke: phase I. Findings of the CLOTBUST Trial. J Neuroimaging. 2004;14(2):113–7. DOI: 10.1177%2F1051228403261462.</p><p>Furlan A, Higashida R, Wechsler L et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA. 1999;282(21):2003–11.</p><p>Sekoranja L, Loulidi J, Yulmaz H. Intravenouse versus combined (intravenous and intra-arterial) thrombolysis in acute ischemic stroke: a transcranial color-coded duplex sonography–guided pilot study. Stroke. 2006;37(7):1805–9. Epub 2006 Jun 8.</p><p>Ciccone A, Valvassori L, Ponzio M et al. The SYNTHESIS Investigators.Ischemic stroke. Intra-arterial or intravenous thrombolysis for acute ischemic stroke? The SYNTHESIS pilot trial. J Neurointerv Surg. 2010;2(1):74–9. DOI: 10.1136/jnis.2009.001388. Epub 2009 Oct 30.</p><p>Moonis M. Intraarterial thrombolysis within the first three hours after acute ischemic stroke in selected patients. Stroke. 2009;40(7):2611–2. DOI: 10.1161/STROKEAHA.109.549568. Epub 2009 May 14.</p><p>Скворцова ВИ, Шамалов НА, Рамазанов ГР и др. Результаты внедрения тромболитической терапии при ишемическом инсульте в Российской Федерации. Журнал неврологии и психиатрии им. С.С. Корсакова. Инсульт. 2010;12:17–22. [Skvortsova VI., Shamalov NA, Ramazanov GR i dr. Rezul'taty vnedreniya tromboliticheskoy terapii pri ishemicheskom insul'te v Rossiyskoy Federatsii. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. Insul't. 2010;12:17–22.]</p></div><br />


For citation:


Pizova N.V. Thrombolytic therapy for ischemic stroke. Neurology, Neuropsychiatry, Psychosomatics. 2013;5(3):55-59. (In Russ.) https://doi.org/10.14412/2074-2711-2013-2342

Views: 500


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)